$HTFL

Farquhar John C.M. sold $608K of HTFL

Farquhar John C.M. (Chief Executive Officer) sold 15,560 shares of Heartflow, Inc. (HTFL) at $39.06 ($0.61M total) on 2026-08-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Farquhar John C.M.
Published Aug 18, 2026, 10:38 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 11:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HTFL
Neutral
medium confidence
Mentioned
$HTFL
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HTFLNeutralLow
01

Why it matters

This is a disclosed CEO open-market sale under a pre-arranged 10b5-1 plan, which generally carries less informational weight than non-10b5-1 selling.

02

Market read

Traders may treat this as routine insider activity with limited fundamental implications, but it can marginally influence sentiment around HTFL.

03

What to watch

The article does not state whether the sale was part of a larger series, nor does it provide context on total holdings changes beyond the post-transaction share count.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-18 after-hours; sale dated 2026-08-14

Background

The article is an SEC Form 4 insider transaction disclosure for Heartflow, Inc. (HTFL).

Company-level read

Ticker impact

$HTFLNeutralMedium confidence
Context

Heartflow CEO Farquhar sold 15,560 shares at $39.0600 on a 10b5-1 plan, disclosing $607,773.60 in insider sales.

Expected impact

Low likelihood of sustained price impact; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction tied to a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary sales.

Market effects

No clear sector read-through from a single 10b5-1 CEO sale.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still reflect liquidity needs or risk management, so traders may watch for follow-on sales or other insider activity.

Key entities

  • Heartflow, Inc.

    Company whose CEO insider sale is disclosed on Form 4.

  • Farquhar John C.M.

    Chief Executive Officer and director who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HTFLMedAI 8/10

Why Heartflow Stock Soared Today

HeartFlow (HTFL) shares rose after the company raised its full-year revenue targets. Revenue grew 48% YoY to $64.1M in Q2, with adjusted gross margin increasing to 83.3%. The company now expects 40-42% revenue growth for 2026, up from prior forecasts. CEO John Farquhar cited improved operating leverage and scalability.

$HTFLMedAI 8/10

Analysts Are Bullish on Heartflow (HTFL) Stock. Here’s Why

Heartflow Inc. (NASDAQ:HTFL) hit a new all-time high after reporting Q2 revenue growth of 48% to $64.08 million from $43.2 million. The company raised full-year revenue guidance to 40% to 42% growth, targeting $246 million to $250 million. Net loss widened to $15.7 million. Analysts at Stifel and JPMorgan raised price targets to $45.